← 產業報告目錄

Healthcare Data Monetization Market by Type (Direct, Indirect), Deployment (On-premise, Cloud), End User (Pharmaceutical & Biotechnology Companies, Healthcare Payers, Healthcare Providers, Medical Technology Companies) & Region- Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-06-18頁數 334報告編號 HIT8682

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global healthcare data monetization market is projected to reach USD 1.16 billion by 2030 from USD 0.58 billion in 2025, at a CAGR of 14.9% during the forecast period. The growth of the market is mainly driven by the increasing volume of medical imaging data, the shift towards enterprise-wide interoperability, and the rising demand for centralized, vendor-neutral platforms that streamline imaging workflows. Additionally, healthcare digitization initiatives and regulatory support for health information exchange are further promoting market expansion. However, high implementation costs and challenges related to data migration continue to hinder the adoption of advanced Vendor Neutral Archives (VNA) and Picture Archiving and Communication Systems (PACS) solutions, particularly among small and mid-sized healthcare providers. “Services, an indirect data monetization segment, will witness the highest growth during the forecast period.” Based on type, the healthcare data monetization market is segmented into direct and indirect data monetization. The direct data monetization segment is divided into software and services. Similarly, the indirect data monetization market is also categorized into software and services. Among these, the services subsegment of indirect data monetization is expected to experience the fastest growth during the forecast period. This growth is driven by the increasing demand for specialized expertise in extracting actionable insights from complex health data. As the focus on advanced analytics, interoperability, and real-world evidence continues to rise, service providers are assisting healthcare organizations in unlocking monetization potential without directly selling data. Companies such as Innovaccer, Komodo Health, and IQVIA offer platforms and consulting services that enable data integration, predictive modeling, and strategic collaborations. These efforts help drive revenue through value-based care, research, and product innovation. “The on-premise segment held the largest segment in the healthcare data monetization market, by deployment model, in 2024.” By deployment model, the on-premise deployment model held the largest share of the healthcare data monetization market in 2024, primarily due to its advantages in data security, control, and compliance. Healthcare organizations handle highly sensitive patient information and must comply with strict regulatory requirements such as HIPAA, GDPR, and national data protection laws. On-premises systems allow these institutions to maintain direct control over their data infrastructure, which enhances protection against breaches and unauthorized access. Many large hospitals and healthcare providers also have legacy systems and IT investments that work more effectively with on-premises solutions, enabling better integration, customization, and performance optimization. This deployment model is especially preferred in regions with strict data residency laws or limited cloud infrastructure, contributing to its significant market share. “The Asia Pacific market is expected to register the highest growth throughout the forecast period.” The Asia Pacific (APAC) region is expected to achieve the highest CAGR in the global healthcare data monetization market during the forecast period. This growth is driven by strong digital health initiatives and the expansion of cloud infrastructure. Initiatives like India’s Ayushman Bharat Digital Mission and China’s Health Information Platform generate large volumes of health data that are well-suited for monetization. Additionally, global technology companies are enhancing regional capabilities, as seen in Microsoft’s USD 2.2 billion investment in Malaysia and Fujitsu’s cloud-based platform in Japan. These developments create a robust foundation for efficient, compliant, and value-driven healthcare data monetization. The breakdown of primary participants is as mentioned below: • By Company Type: Tier 1: 45%, Tier 2: 30%, and Tier 3: 25% • By Designation: C-level: 42%, Director-level: 31%, and Others: 27% • By Region: North America: 35%, Europe: 30%, Asia Pacific: 25%, Middle East & Africa: 5%, Latin America: 5% Key Players in the Healthcare Data Monetization Market The key players functioning in the healthcare data monetization market include Oracle Corporation (US), Microsoft Corporation (US), Google (US), Salesforce, Inc. (US), SAS Institute Inc. (US), SAP SE (Germany), TIBCO Software Inc. (US), Sisense Inc. (US), Snowflake Inc. (US), QlikTech International AB (US), HealthVerity, Inc. (US), Accenture (Ireland), Availity, LLC (US), Domo, Inc. (US), Komodo Health, Inc. (US), ThoughtSpot Inc. (US), Datavant (US), Verato (US), Infor, Inc. (US), Virtusa (US), Infosys (India), Particle Health, Inc. (US), Innovaccer, Inc. (US), H1 (US), and Medable Inc. (US). Research Coverage: The report analyzes the healthcare data monetization market. It aims to estimate the market size and future growth potential of various market segments based on type, deployment type, end-user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report This report will help established firms and new entrants/smaller firms gauge the market’s pulse, which would help them garner a greater market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their positions in the market. This report provides insights on:  Analysis of key drivers (rising volume of healthcare data, shift toward value-based care, advancements in AI and analytics), restraints (data privacy and regulatory concerns, lack of standardization and interoperability), opportunities (emergence of cloud-based data platforms, growing demand for real-world evidence (RWE)), and challenges (ethical concerns around data ownership and consent, limited digital maturity among healthcare providers) influencing the growth of the market.  Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare data monetization market.  Market Development: Comprehensive information on the lucrative emerging markets, type, deployment, end user, and region.  Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare data monetization market.  Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare data monetization market like Oracle Corporation (US), Microsoft Corporation (US), Google (US), Salesforce (US), SAS Institute (US), and SAP (Germany).
目錄 Table of Contents
1 INTRODUCTION 29 1.1 STUDY OBJECTIVES 29 1.2 MARKET DEFINITION 29 1.3 INCLUSIONS AND EXCLUSIONS 30 1.4 MARKET SCOPE 31 1.4.1 MARKET SEGMENTATION 31 1.5 YEARS CONSIDERED 32 1.6 CURRENCY CONSIDERED 32 1.7 LIMITATIONS 33 1.8 STAKEHOLDERS 33 2 RESEARCH METHODOLOGY 35 2.1 RESEARCH DATA 35 2.2 RESEARCH APPROACH 36 2.2.1 SECONDARY RESEARCH 36 2.2.1.1 Key data from secondary sources 37 2.2.2 PRIMARY RESEARCH 37 2.2.2.1 Key primary sources 38 2.2.2.2 Key data from primary sources 39 2.2.2.3 Key industry insights 39 2.2.2.4 Breakdown of primary interviews 40 2.3 RESEARCH METHODOLOGY DESIGN 40 2.4 MARKET SIZE ESTIMATION 41 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 47 2.6 RESEARCH ASSUMPTIONS 48 2.7 RISK ASSESSMENT 49 2.8 RESEARCH LIMITATIONS 50 2.8.1 METHODOLOGY-RELATED LIMITATIONS 50 2.8.2 SCOPE-RELATED LIMITATIONS 50 3 EXECUTIVE SUMMARY 51 4 PREMIUM INSIGHTS 55 4.1 OPPORTUNITIES IN HEALTHCARE DATA MONETIZATION MARKET 55 4.2 HEALTHCARE DATA MONETIZATION MARKET, BY REGION 56 4.3 HEALTHCARE DATA MONETIZATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56 4.4 HEALTHCARE DATA MONETIZATION MARKET IN NORTH AMERICA, BY END USER AND COUNTRY 57 4.5 HEALTHCARE DATA MONETIZATION MARKET: DEVELOPED VS. EMERGING MARKETS 58 5 MARKET OVERVIEW 59 5.1 INTRODUCTION 59 5.2 MARKET DYNAMICS 59 5.2.1 DRIVERS 60 5.2.1.1 Growing use of external data sources 60 5.2.1.2 Increasing adoption of electronic health records (EHRs) 61 5.2.1.3 Growing volume of large and complex healthcare datasets 61 5.2.1.4 Rising need to curtail escalating healthcare costs 62 5.2.2 RESTRAINTS 64 5.2.2.1 Lack of data standardization and interoperability 64 5.2.2.2 Regulatory constraints 65 5.2.3 OPPORTUNITIES 66 5.2.3.1 Rising demand for real-world evidence 66 5.2.3.2 Emergence of personalized medicine and genomics 67 5.2.4 CHALLENGES 68 5.2.4.1 Security concerns 68 5.3 INDUSTRY TRENDS 71 5.3.1 HIGH DEMAND FOR OUTCOME-LINKED DATA MONETIZATION DUE TO SURGE IN VALUE-BASED CARE 71 5.3.2 SIGNIFICANT DEMAND FOR REAL-WORLD DATA (RWD) BY PHARMA COMPANIES FOR DRUG DEVELOPMENT 72 5.3.3 EMERGENCE OF HEALTH DATA MARKETPLACES FOR DATA EXCHANGE 72 5.3.4 GROWTH IN CONSUMER-GENERATED HEALTH DATA 73 5.4 TYPES OF HEALTHCARE DATA MONETIZATION SOLUTIONS 73 5.4.1 DIRECT DATA MONETIZATION 74 5.4.2 INDIRECT DATA MONETIZATION 74 5.5 TECHNOLOGY ANALYSIS 75 5.5.1 DATA AS A SERVICE 75 5.5.2 INSIGHT AS A SERVICE 75 5.5.3 ANALYTICS-ENABLED PLATFORM AS A SERVICE 75 5.5.4 EMBEDDED ANALYTICS 75 5.5.5 ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML) 76 5.6 REGULATORY LANDSCAPE 76 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 76 5.6.2 REGULATIONS 77 5.7 SUPPLY CHAIN ANALYSIS 79 5.8 ECOSYSTEM ANALYSIS 81 5.9 PATENT ANALYSIS 82 5.9.1 PATENT PUBLICATION TRENDS IN HEALTHCARE DATA MONETIZATION MARKET 82 5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 82   5.10 CASE STUDY ANALYSIS 87 5.10.1 CASE STUDY 1: ACCOLADE REDUCES PATIENT ONBOARDING TIME BY DEPLOYING AWS-INTEGRATED DATA FABRIC SOLUTION 87 5.10.2 CASE STUDY 2: LEADING HEALTHCARE REVENUE MANAGEMENT COMPANY ADOPTS TIBCO SOFTWARE TO CUT DEVELOPER COSTS BY 50% 87 5.10.3 CASE STUDY 3: SAKURA FINETEK EUROPE FUTURE-PROOFS ITS BUSINESS BY DEPLOYING ORACLE CLOUD APPLICATIONS 88 5.10.4 CASE STUDY 4: AMERISOURCEBERGEN GAINS FINANCE EFFICIENCIES USING ORACLE CLOUD EPM 89 5.10.5 CASE STUDY 5: SKYGEN IMPROVES FINANCIAL VISIBILITY USING ORACLE CLOUD ERP AND EPM 90 5.10.6 CASE STUDY 6: HEALTH FIRST USES AZURE SYNAPSE ANALYTICS TO CREATE A DATA MANAGEMENT SOLUTION AND IMPROVE REFRESH SPEEDS BY 75% 91 5.10.7 CASE STUDY 7: COMMERCIAL UNDERWRITER ADOPTS HEALTHVERITY’S HVID SOLUTION TO CALIBRATE RISKS IN INSURANCE POLICIES 92 5.10.8 CASE STUDY 8: PHARMA COMPANIES USE HEALTHVERITY’S HVID SOLUTION IN PRAGMATIC CLINICAL TRIALS TO TRACK TREATMENT AND CLINICALLY RELEVANT OUTCOMES 92 5.10.9 CASE STUDY 9: PHARMA COMPANIES ADOPT HEALTHVERITY’S HVID SOLUTION TO IDENTIFY HEART FAILURE PATIENTS 93 5.10.10 CASE STUDY 10: PHARMA COMPANIES DEPLOY HEALTHVERITY MARKETPLACE AND CENSUS SOLUTIONS FOR CLINICAL TRIAL ANALYSIS 93 5.11 PORTER’S FIVE FORCES ANALYSIS 94 5.11.1 THREAT OF NEW ENTRANTS 95 5.11.2 THREAT OF SUBSTITUTES 95 5.11.3 BARGAINING POWER OF SUPPLIERS 95 5.11.4 BARGAINING POWER OF BUYERS 95 5.11.5 INTENSITY OF COMPETITIVE RIVALRY 96 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 96 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 96 5.12.2 BUYING CRITERIA 97 5.13 KEY CONFERENCES AND EVENTS, 2025 98 5.14 AVERAGE SELLING PRICE: DATA MONETIZATION MARKET 98 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 102 6 IMPACT OF 2025 US TARIFF ON HEATHCARE DATA MONETIZATION MARKET 104 6.1 INTRODUCTION 104 6.2 KEY TARIFF RATES 105 6.3 PRICE IMPACT ANALYSIS 105 6.4 IMPACT ON COUNTRY/REGION 106 6.4.1 US 106 6.4.2 EUROPE 106 6.4.3 ASIA PACIFIC 107   6.5 IMPACT ON END USERS 108 6.5.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 108 6.5.1.1 Clinical trial data analytics 108 6.5.1.2 Real-world evidence platforms 108 6.5.1.3 Genomics and precision medicines 108 6.5.1.4 Supply chain data analytics 109 6.5.1.5 Regulatory compliance 109 6.5.2 HEALTHCARE PAYERS 109 6.5.2.1 Claims analytics platforms 109 6.5.2.2 Population health management 109 6.5.2.3 Risk assessment and underwriting 109 6.5.2.4 Regulatory reporting 109 6.5.2.5 Market consolidation 109 6.5.3 HEALTHCARE SERVICE PROVIDERS 109 6.5.3.1 Clinical decision support 110 6.5.3.2 Operational analytics 110 6.5.3.3 Research and clinical trials 110 6.5.3.4 Benchmarking and comparative analytics 110 6.5.3.5 Technology integration 110 6.5.4 MEDTECH COMPANIES 110 6.5.4.1 Product development analytics 110 6.5.4.2 Post-market surveillance 110 6.5.4.3 Device data monetization 110 6.5.4.4 Regulatory compliance 111 6.5.4.5 Supply chain integration 111 6.5.5 DIGITAL HEALTH COMPANIES 111 6.5.6 HEALTHCARE CONSULTING FIRMS 111 6.5.7 ACADEMIC RESEARCH INSTITUTIONS 111 6.5.8 GOVERNMENT AGENCIES 111 7 HEALTHCARE DATA MONETIZATION MARKET, BY TYPE 112 7.1 INTRODUCTION 113 7.2 DIRECT DATA MONETIZATION 114 7.2.1 SOFTWARE 116 7.2.1.1 Rising adoption of AI, ML, and blockchain technologies to enhance value proposition of data assets to drive market 116 7.2.2 SERVICES 117 7.2.2.1 Cloud-based infrastructure, scalability, and cost-effectiveness to improve adoption of direct data monetization services 117 7.3 INDIRECT DATA MONETIZATION 118 7.3.1 SOFTWARE 119 7.3.1.1 Growing focus on data analytics and insights to support market growth 119 7.3.2 SERVICES 121 7.3.2.1 Rising emphasis on advanced data analytics and actionable insights to contribute to market growth 121 8 HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE 123 8.1 INTRODUCTION 124 8.1.1 CLINICAL DATA 124 8.1.1.1 Rising use of AI and ML to extract actionable insights from clinical data to create opportunities 124 8.1.2 CLINICAL TRIAL DATA 125 8.1.2.1 Growing demand for real-world evidence and AI-driven trial optimization to drive market 125 8.1.3 CLAIMS AND BILLING DATA 126 8.1.3.1 Surging requirement for value-based care and cost transparency to boost segmental growth 126 8.1.4 CONSUMER AND DIGITAL HEALTH DATA 126 8.1.4.1 Elevating demand for chronic disease management and predictive healthcare services to support market growth 126 8.1.5 GENOMIC AND MOLECULAR DATA 127 8.1.5.1 Rising preference for precision and personalized medicines to foster market growth 127 8.1.6 OTHER DATA TYPES 128 9 HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT 129 9.1 INTRODUCTION 130 9.2 ON-PREMISES 130 9.2.1 EMPHASIS ON MINIMIZING DATA EXPOSURE TO THIRD-PARTY ENVIRONMENTS TO BOOST SEGMENTAL GROWTH 130 9.3 CLOUD-BASED 131 9.3.1 FOCUS ON OPTIMIZING DEPLOYMENT COSTS TO FUEL SEGMENTAL GROWTH 131 10 HEALTHCARE DATA MONETIZATION MARKET, BY END USER 133 10.1 INTRODUCTION 134 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 134 10.2.1 RISING USE OF RWD AND RWE TO ACCELERATE MARKET GROWTH 134 10.3 HEALTHCARE PAYERS 135 10.3.1 PRESSING NEED TO DESIGN INNOVATIVE VALUE-BASED CARE MODELS TO CREATE OPPORTUNITIES 135 10.4 HEALTHCARE PROVIDERS 136 10.4.1 URGENT REQUIREMENT TO OPTIMIZE CLINICAL WORKFLOWS AND IDENTIFY HIGH-RISK POPULATIONS TO BOOST MARKET GROWTH 136 10.5 MEDICAL TECHNOLOGY COMPANIES 137 10.5.1 INCREASING PENETRATION OF CONNECTED MEDICAL DEVICES AND WEARABLES TO PROPEL MARKET 137 10.6 OTHER END USERS 138 11 HEALTHCARE DATA MONETIZATION MARKET, BY REGION 139 11.1 INTRODUCTION 140 11.2 NORTH AMERICA 140 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 141 11.2.2 US 144 11.2.2.1 Inclination toward value-based care and outcome-focused healthcare models to stimulate demand 144 11.2.3 CANADA 147 11.2.3.1 Growing digitization of healthcare records to boost adoption 147 11.3 EUROPE 150 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 150 11.3.2 UK 153 11.3.2.1 Growing use of wearable medical devices to fuel market growth 153 11.3.3 GERMANY 155 11.3.3.1 Government initiatives to develop digital healthcare ecosystem to create opportunities 155 11.3.4 FRANCE 158 11.3.4.1 Government initiatives promoting digital health roadmap to boost demand 158 11.3.5 ITALY 160 11.3.5.1 Focus of healthcare sector on digital transformation to support market growth 160 11.3.6 SPAIN 163 11.3.6.1 Surging demand for predictive analytics and value-based care models to fuel market growth 163 11.3.7 REST OF EUROPE 165 11.4 ASIA PACIFIC 168 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 168 11.4.2 JAPAN 172 11.4.2.1 Elevating need for effective patient management solutions with increasing geriatric population to drive market 172 11.4.3 CHINA 175 11.4.3.1 High prevalence of chronic diseases to drive demand 175 11.4.4 INDIA 177 11.4.4.1 Government initiatives to create unified digital health ecosystem to foster market growth 177 11.4.5 REST OF ASIA PACIFIC 180 11.5 LATIN AMERICA 182 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 183 11.5.2 BRAZIL 185 11.5.2.1 Government initiatives to digitize patient records to boost demand 185 11.5.3 MEXICO 188 11.5.3.1 Rising adoption of telemedicine and mobile health platforms to drive market 188 11.5.4 REST OF LATIN AMERICA 190 11.6 MIDDLE EAST & AFRICA 192 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 193 11.6.2 GCC 195 11.6.2.1 National digital health visions and AI-driven healthcare transformation to propel market 195 11.6.3 REST OF MIDDLE EAST & AFRICA 198 12 COMPETITIVE LANDSCAPE 201 12.1 OVERVIEW 201 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 201 12.3 REVENUE ANALYSIS, 2020–2024 204 12.4 MARKET SHARE ANALYSIS, 2024 206 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 208 12.5.1 STARS 208 12.5.2 EMERGING LEADERS 208 12.5.3 PERVASIVE PLAYERS 208 12.5.4 PARTICIPANTS 208 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 210 12.5.5.1 Company footprint 210 12.5.5.2 Region footprint 211 12.5.5.3 Type footprint 212 12.5.5.4 End user footprint 213 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 214 12.6.1 PROGRESSIVE COMPANIES 214 12.6.2 RESPONSIVE COMPANIES 214 12.6.3 DYNAMIC COMPANIES 214 12.6.4 STARTING BLOCKS 214 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 216 12.6.5.1 Detailed list of key startups/SMEs 216 12.6.5.2 Competitive benchmarking of key startups/SMEs 217 12.7 COMPANY VALUATION AND FINANCIAL METRICS 218 12.7.1 FINANCIAL METRICS 218 12.7.2 COMPANY VALUATION 218 12.8 BRAND/SOFTWARE COMPARISON 219 12.9 COMPETITIVE SCENARIO 219 12.9.1 PRODUCT LAUNCHES & ENHANCEMENTS 219 12.9.2 DEALS 221   13 COMPANY PROFILES 222 13.1 KEY PLAYERS 222 13.1.1 ORACLE 222 13.1.1.1 Business overview 222 13.1.1.2 Products offered 224 13.1.1.3 Recent developments 225 13.1.1.3.1 Product launches & enhancements 225 13.1.1.3.2 Deals 227 13.1.1.4 MnM view 229 13.1.1.4.1 Right to win 229 13.1.1.4.2 Strategic choices 229 13.1.1.4.3 Weaknesses & competitive threats 229 13.1.2 MICROSOFT 230 13.1.2.1 Business overview 230 13.1.2.2 Products offered 231 13.1.2.3 Recent developments 232 13.1.2.3.1 Product launches & enhancements 232 13.1.2.3.2 Deals 234 13.1.2.4 MnM view 235 13.1.2.4.1 Right to win 235 13.1.2.4.2 Strategic choices 236 13.1.2.4.3 Weaknesses & competitive threats 236 13.1.3 GOOGLE 237 13.1.3.1 Business overview 237 13.1.3.2 Products offered 238 13.1.3.3 Recent developments 239 13.1.3.3.1 Product launches & enhancements 239 13.1.3.3.2 Deals 241 13.1.3.4 MnM view 243 13.1.3.4.1 Right to win 243 13.1.3.4.2 Strategic choices 243 13.1.3.4.3 Weaknesses & competitive threats 243 13.1.4 SALESFORCE, INC. 244 13.1.4.1 Business overview 244 13.1.4.2 Products offered 245 13.1.4.3 Recent developments 247 13.1.4.3.1 Product launches & enhancements 247 13.1.4.3.2 Deals 249 13.1.4.4 MnM view 250 13.1.4.4.1 Right to win 250 13.1.4.4.2 Strategic choices 250 13.1.4.4.3 Weaknesses & competitive threats 250 13.1.5 SAS INSTITUTE INC. 251 13.1.5.1 Business overview 251 13.1.5.2 Products offered 252 13.1.5.3 Recent developments 253 13.1.5.3.1 Product launches & enhancements 253 13.1.5.3.2 Deals 254 13.1.5.4 MnM view 255 13.1.5.4.1 Right to win 255 13.1.5.4.2 Strategic choices 255 13.1.5.4.3 Weaknesses & competitive threats 255 13.1.6 SAP SE 256 13.1.6.1 Business overview 256 13.1.6.2 Products offered 257 13.1.6.3 Recent developments 259 13.1.6.3.1 Product launches & enhancements 259 13.1.6.3.2 Deals 261 13.1.7 TIBCO SOFTWARE INC. 263 13.1.7.1 Business overview 263 13.1.7.2 Products offered 263 13.1.7.3 Recent developments 264 13.1.7.3.1 Product launches & enhancements 264 13.1.7.3.2 Deals 266 13.1.8 SNOWFLAKE INC. 267 13.1.8.1 Business overview 267 13.1.8.2 Products offered 268 13.1.8.3 Recent developments 269 13.1.8.3.1 Product launches & enhancements 269 13.1.8.3.2 Deals 270 13.1.9 QLIKTECH INTERNATIONAL AB 272 13.1.9.1 Business overview 272 13.1.9.2 Products offered 272 13.1.9.3 Recent developments 273 13.1.9.3.1 Product launches & enhancements 273 13.1.9.3.2 Deals 274 13.1.10 INFOSYS LIMITED 276 13.1.10.1 Business overview 276 13.1.10.2 Products offered 277 13.1.10.3 Recent developments 279 13.1.10.3.1 Deals 279   13.1.11 SISENSE INC. 280 13.1.11.1 Business overview 280 13.1.11.2 Products offered 280 13.1.11.3 Recent developments 281 13.1.11.3.1 Product launches & enhancements 281 13.1.11.3.2 Deals 281 13.1.12 ACCENTURE 282 13.1.12.1 Business overview 282 13.1.12.2 Products offered 283 13.1.12.3 Recent developments 284 13.1.12.3.1 Product launches & enhancements 284 13.1.12.3.2 Deals 285 13.1.13 AVAILITY, LLC 287 13.1.13.1 Business overview 287 13.1.13.2 Products offered 287 13.1.13.3 Recent developments 288 13.1.13.3.1 Product launches & enhancements 288 13.1.13.3.2 Deals 289 13.1.14 DOMO, INC. 291 13.1.14.1 Business overview 291 13.1.14.2 Products offered 293 13.1.14.3 Recent developments 293 13.1.14.3.1 Product launches & enhancements 293 13.1.14.3.2 Deals 296 13.1.15 KOMODO HEALTH, INC. 297 13.1.15.1 Business overview 297 13.1.15.2 Products offered 297 13.1.15.3 Recent developments 298 13.1.15.3.1 Product launches & enhancements 298 13.1.15.3.2 Deals 299 13.1.16 VIRTUSA 301 13.1.16.1 Business overview 301 13.1.16.2 Products offered 301 13.1.16.3 Recent developments 302 13.1.16.3.1 Product launches & enhancements 302 13.1.16.3.2 Deals 302 13.1.17 DATAVANT 304 13.1.17.1 Business overview 304 13.1.17.2 Products offered 304 13.1.17.3 Recent developments 305 13.1.17.3.1 Product launches & enhancements 305 13.1.17.3.2 Deals 306 13.1.18 INFOR, INC. 310 13.1.18.1 Business overview 310 13.1.18.2 Products offered 310 13.1.18.3 Recent developments 311 13.1.18.3.1 Product launches & enhancements 311 13.1.19 HEALTHVERITY, INC. 312 13.1.19.1 Business overview 312 13.1.19.2 Products offered 312 13.1.19.3 Recent developments 313 13.1.19.3.1 Product launches & enhancements 313 13.1.19.3.2 Deals 314 13.1.20 THOUGHTSPOT INC. 316 13.1.20.1 Business overview 316 13.1.20.2 Products offered 316 13.1.20.3 Recent developments 317 13.1.20.3.1 Product launches & enhancements 317 13.1.20.3.2 Deals 318 13.2 OTHER PLAYERS 318 13.2.1 VERATO 318 13.2.2 PARTICLE HEALTH, INC. 319 13.2.3 INNOVACCER, INC. 320 13.2.4 H1 321 13.2.5 MEDABLE INC. 322 14 APPENDIX 323 14.1 DISCUSSION GUIDE 323 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 329 14.3 CUSTOMIZATION OPTIONS 331 14.4 RELATED REPORTS 332 14.5 AUTHOR DETAILS 333
圖表清單 List of Tables & Figures
TABLE 1 EXCHANGE RATES CONSIDERED FOR CONVERSION TO USD 32 TABLE 2 FACTOR ANALYSIS 45 TABLE 3 ASSUMPTIONS FOR RESEARCH STUDY 48 TABLE 4 LIMITATIONS AND ASSOCIATED RISKS 49 TABLE 5 MAJOR HEALTHCARE DATA BREACHES (2021–2025) 69 TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 7 NORTH AMERICA: REGULATIONS 77 TABLE 8 EUROPE: REGULATIONS 78 TABLE 9 ASIA PACIFIC: REGULATIONS 78 TABLE 10 MIDDLE EAST & SOUTH AFRICA: REGULATIONS 79 TABLE 11 LATIN AMERICA: REGULATIONS 79 TABLE 12 HEALTHCARE DATA MONETIZATION MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2022–2025 84 TABLE 13 HEALTHCARE DATA MONETIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS 94 TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 96 TABLE 15 KEY BUYING CRITERIA, BY END USER (%) 97 TABLE 16 HEALTHCARE DATA MONETIZATION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 98 TABLE 17 COMMONLY ADOPTED PRICING STRATEGIES IN HEALTHCARE DATA MONETIZATION MARKET 98 TABLE 18 MICROSOFT CORPORATION: PRICING OF AZURE HEALTH DATA SERVICES 99 TABLE 19 MICROSOFT CORPORATION: PRICING OF AZURE API FOR FHIR 99 TABLE 20 MICROSOFT CORPORATION: PRICING OF AZURE DATA SHARE 100 TABLE 21 MICROSOFT CORPORATION: PRICING OF MEDIA SERVICES 100 TABLE 22 SALESFORCE, INC.: PRICING OF HEALTH CLOUD 100 TABLE 23 SALESFORCE, INC.: PRICING OF DATA CLOUD FOR HEALTH 101 TABLE 24 SALESFORCE, INC.: PRICING OF ADDITIONAL SOLUTIONS 101 TABLE 25 US-ADJUSTED RECIPROCAL TARIFF RATES 105 TABLE 26 HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 113 TABLE 27 HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 115 TABLE 28 DIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 29 DIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET FOR SOFTWARE, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 30 DIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET FOR SERVICES, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 31 HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 119 TABLE 32 INDIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 33 INDIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET FOR SOFTWARE, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 34 INDIRECT DATA MONETIZATION: HEALTHCARE DATA MONETIZATION MARKET FOR SERVICES, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 35 HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 124 TABLE 36 CLINICAL DATA: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 37 CLINICAL TRIAL DATA: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 38 CLAIMS AND BILLING DATA: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 39 CONSUMER AND DIGITAL HEALTH DATA: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 40 GENOMIC AND MOLECULAR DATA: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 41 OTHER DATA TYPES: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 42 HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 130 TABLE 43 ON-PREMISES: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 44 CLOUD-BASED: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 45 HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 134 TABLE 46 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 47 HEALTHCARE PAYERS: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 48 HEALTHCARE PROVIDERS: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 49 MEDICAL TECHNOLOGY COMPANIES: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 50 OTHER END USERS: HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 51 HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 52 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 53 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 143 TABLE 54 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING 2023–2030 (USD MILLION) 143 TABLE 55 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 143 TABLE 56 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 143 TABLE 57 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 144 TABLE 58 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 144 TABLE 59 US: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 60 US: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 145 TABLE 61 US: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 146 TABLE 62 US: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 146 TABLE 63 US: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 146 TABLE 64 US: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 65 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 148 TABLE 66 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 148 TABLE 67 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING 2023–2030 (USD MILLION) 148 TABLE 68 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 149 TABLE 69 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 149 TABLE 70 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 149 TABLE 71 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 72 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 73 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 151 TABLE 74 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 152 TABLE 75 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 152 TABLE 76 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 152 TABLE 77 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 153 TABLE 78 UK: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 79 UK: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 154 TABLE 80 UK: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 154 TABLE 81 UK: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 154 TABLE 82 UK: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 155 TABLE 83 UK: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 155 TABLE 84 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 85 GERMANY: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 156 TABLE 86 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 157 TABLE 87 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 157 TABLE 88 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 157 TABLE 89 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 158 TABLE 90 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 91 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION TYPE, 2023–2030 (USD MILLION) 159 TABLE 92 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION TYPE, 2023–2030 (USD MILLION) 159 TABLE 93 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 159 TABLE 94 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 160 TABLE 95 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 96 ITALY: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 97 ITALY: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 161 TABLE 98 ITALY: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 162 TABLE 99 ITALY: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 162 TABLE 100 ITALY: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 162 TABLE 101 ITALY: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 102 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 103 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 164 TABLE 104 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 164 TABLE 105 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 164 TABLE 106 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 165 TABLE 107 SPAIN: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 165 TABLE 108 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 109 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 166 TABLE 110 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 167 TABLE 111 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 167 TABLE 112 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 167 TABLE 113 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 168 TABLE 114 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 115 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 116 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING , 2023–2030 (USD MILLION) 170 TABLE 117 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING , 2023–2030 (USD MILLION) 171 TABLE 118 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 171 TABLE 119 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 171 TABLE 120 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 121 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 122 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING , 2023–2030 (USD MILLION) 173 TABLE 123 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 173 TABLE 124 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 174 TABLE 125 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 174 TABLE 126 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 174 TABLE 127 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 128 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 176 TABLE 129 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 176 TABLE 130 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 176 TABLE 131 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 177 TABLE 132 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 177 TABLE 133 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 134 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 178 TABLE 135 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 178 TABLE 136 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 179 TABLE 137 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 179 TABLE 138 INDIA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 139 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 140 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 181 TABLE 141 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 181 TABLE 142 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 181 TABLE 143 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 182 TABLE 144 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 182 TABLE 145 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 146 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 147 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 184 TABLE 148 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 184 TABLE 149 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 184 TABLE 150 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 185 TABLE 151 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 185 TABLE 152 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 153 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 186 TABLE 154 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 186 TABLE 155 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 187 TABLE 156 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 187 TABLE 157 BRAZIL: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 158 MEXICO: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 159 MEXICO: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 188 TABLE 160 MEXICO: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 189 TABLE 161 MEXICO: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 189 TABLE 162 MEXICO: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 189 TABLE 163 MEXICO: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 190 TABLE 164 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 165 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 191 TABLE 166 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION TYPE, 2023–2030 (USD MILLION) 191 TABLE 167 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 191 TABLE 168 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 192 TABLE 169 REST OF LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 170 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 171 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 172 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 194 TABLE 173 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION TYPE, 2023–2030 (USD MILLION) 194 TABLE 174 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 194 TABLE 175 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 195 TABLE 176 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 195 TABLE 177 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 178 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 196 TABLE 179 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 196 TABLE 180 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 197 TABLE 181 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 197 TABLE 182 GCC: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 197 TABLE 183 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 184 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY DIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 198 TABLE 185 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY INDIRECT DATA MONETIZATION OFFERING, 2023–2030 (USD MILLION) 199 TABLE 186 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023–2030 (USD MILLION) 199 TABLE 187 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY DATA TYPE, 2023–2030 (USD MILLION) 199 TABLE 188 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023–2030 (USD MILLION) 200 TABLE 189 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE DATA MONETIZATION MARKET, JANUARY 2022–MAY 2025 202 TABLE 190 HEALTHCARE DATA MONETIZATION MARKET: DEGREE OF COMPETITION 207 TABLE 191 HEALTHCARE DATA MONETIZATION MARKET: REGION FOOTPRINT 211 TABLE 192 HEALTHCARE DATA MONETIZATION MARKET: TYPE FOOTPRINT 212 TABLE 193 HEALTHCARE DATA MONETIZATION MARKET: END USER FOOTPRINT 213 TABLE 194 HEALTHCARE DATA MONETIZATION MARKET: DETAILED LIST OF KEY SMES/STARTUPS 216 TABLE 195 HEALTHCARE DATA MONETIZATION MARKET: COMPETITIVE BENCHMARKING OF KEY SMES SMES/STARTUPS 217 TABLE 196 HEALTHCARE DATA MONETIZATION MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 220 TABLE 197 HEALTHCARE DATA MONETIZATION MARKET: DEALS, JANUARY 2022–MAY 2025 221 TABLE 198 ORACLE: COMPANY OVERVIEW 222 TABLE 199 ORACLE: PRODUCTS OFFERED 224 TABLE 200 ORACLE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 225 TABLE 201 ORACLE: DEALS, JANUARY 2022–MAY 2025 227 TABLE 202 MICROSOFT: COMPANY OVERVIEW 230 TABLE 203 MICROSOFT: PRODUCTS OFFERED 231 TABLE 204 MICROSOFT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 232 TABLE 205 MICROSOFT: DEALS, JANUARY 2022–MAY 2025 234 TABLE 206 GOOGLE: COMPANY OVERVIEW 237 TABLE 207 GOOGLE: PRODUCTS OFFERED 238 TABLE 208 GOOGLE: PRODUCT LAUNCHES & ENHANCEMENTS, ENHANCEMENTS JANUARY 2021–MAY 2025 239 TABLE 209 GOOGLE: DEALS, JANUARY 2021–MAY 2025 241 TABLE 210 SALESFORCE, INC.: COMPANY OVERVIEW 244 TABLE 211 SALESFORCE INC.: PRODUCTS OFFERED 245 TABLE 212 SALESFORCE INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–MAY 2025 247 TABLE 213 SALESFORCE INC.: DEALS, JANUARY 2022–MAY 2025 249 TABLE 214 SAS INSTITUTE INC.: COMPANY OVERVIEW 251 TABLE 215 SAS INSTITUTE INC.: PRODUCTS OFFERED 252 TABLE 216 SAS INSTITUTE INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–MAY 2025 253 TABLE 217 SAS INSTITUTE INC.: DEALS, JANUARY 2021–MAY 2025 254 TABLE 218 SAP SE: COMPANY OVERVIEW 256 TABLE 219 SAP SE: PRODUCTS OFFERED 257 TABLE 220 SAP SE: PRODUCT LAUNCHES & ENHANCEMENTS, ENHANCEMENT JANUARY 2022–MAY 2025 259 TABLE 221 SAP SE: DEALS, JANUARY 2021–MAY 2025 261 TABLE 222 TIBCO SOFTWARE INC.: COMPANY OVERVIEW 263 TABLE 223 TIBCO SOFTWARE INC.: PRODUCTS OFFERED 263 TABLE 224 TIBCO SOFTWARE INC.: PRODUCT LAUNCHES, APPROVALS, & ENHANCEMENT JANUARY 2022–MAY 2025 264 TABLE 225 TIBCO SOFTWARE INC: DEALS, JANUARY 2022–MAY 2025 266 TABLE 226 SNOWFLAKE INC.: COMPANY OVERVIEW 267 TABLE 227 SNOWFLAKE INC.: PRODUCTS OFFERED 268 TABLE 228 SNOWFLAKE INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 269 TABLE 229 SNOWFLAKE INC.: DEALS, JANUARY 2021–MAY 2025 270 TABLE 230 QLIKTECH INTERNATIONAL AB: COMPANY OVERVIEW 272 TABLE 231 QLIKTECH INTERNATIONAL AB: PRODUCTS OFFERED 272 TABLE 232 QLIKTECH INTERNATIONAL AB: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–MAY 2025 273 TABLE 233 QLIKTECH INTERNATIONAL AB: DEALS, JANUARY 2021–MAY 2025 274 TABLE 234 INFOSYS LIMITED: COMPANY OVERVIEW 276 TABLE 235 INFOSYS LIMITED: PRODUCTS OFFERED 277 TABLE 236 INFOSYS LIMITED: DEALS, JANUARY 2021–MAY 2025 279 TABLE 237 SISENSE INC.: COMPANY OVERVIEW 280 TABLE 238 SISENSE INC.: PRODUCTS OFFERED 280 TABLE 239 SISENSE INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 281 TABLE 240 SISENSE INC.: DEALS, JANUARY 2022–MAY 2025 281 TABLE 241 ACCENTURE: COMPANY OVERVIEW 282 TABLE 242 ACCENTURE: PRODUCTS OFFERED 283 TABLE 243 ACCENTURE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–FEBRUARY 2025 284 TABLE 244 ACCENTURE: DEALS, JANUARY 2022–MAY 2025 285 TABLE 245 AVAILITY, LLC: COMPANY OVERVIEW 287 TABLE 246 AVAILITY, LLC: PRODUCTS OFFERED 287 TABLE 247 ATHENAHEALTH, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–MAY 2025 288 TABLE 248 ATHENAHEALTH, INC.: DEALS, JANUARY 2022–MAY 2025 289 TABLE 249 DOMO, INC.: COMPANY OVERVIEW 291 TABLE 250 DOMO, INC.: PRODUCTS OFFERED 293 TABLE 251 DOMO, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–MAY 2025 293 TABLE 252 DOMO, INC.: DEALS, JANUARY 2022–MAY 2025 296 TABLE 253 KOMODO HEALTH, INC.: COMPANY OVERVIEW 297 TABLE 254 KOMODO HEALTH, INC.: PRODUCTS OFFERED 297 TABLE 255 KOMODO HEALTH, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 298 TABLE 256 KOMODO HEALTH, INC.: DEALS, JANUARY 2021–MAY 2025 299 TABLE 257 VIRTUSA: COMPANY OVERVIEW 301 TABLE 258 VIRTUSA: PRODUCTS OFFERED 301 TABLE 259 VIRTUSA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–MAY 2025 302 TABLE 260 VIRTUSA: DEALS, JANUARY 2021–MAY 2025 302 TABLE 261 DATAVANT: COMPANY OVERVIEW 304 TABLE 262 DATAVANT: PRODUCTS OFFERED 304 TABLE 263 DATAVANT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 305 TABLE 264 DATAVANT.: DEALS, JANUARY 2022–MAY 2025 306 TABLE 265 INFOR, INC.: COMPANY OVERVIEW 310 TABLE 266 INFOR, INC.: PRODUCTS OFFERED 310 TABLE 267 INFOR, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 311 TABLE 268 HEALTHVERITY, INC.: COMPANY OVERVIEW 312 TABLE 269 HEALTHVERITY, INC.: PRODUCTS OFFERED 312 TABLE 270 HEALTHVERITY, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–MAY 2025 313 TABLE 271 HEALTHVERITY, INC.: DEALS, JANUARY 2021–MAY 2025 314 TABLE 272 THOUGHTSPOT INC.: COMPANY OVERVIEW 316 TABLE 273 THOUGHTSPOT INC.: PRODUCTS OFFERED 316 TABLE 274 THOUGHTSPOT INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–MAY 2025 317 TABLE 275 THOUGHTSPOT INC.: DEALS, JANUARY 2021–MAY 2025 318 FIGURE 1 HEALTHCARE DATA MONETIZATION MARKET: MARKET SEGMENTATION 31 FIGURE 2 RESEARCH DESIGN 35 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40 FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 41 FIGURE 5 APPROACH FOR ASSESSING SUPPLY OF HEALTHCARE DATA MONETIZATION SOLUTIONS 42 FIGURE 6 BOTTOM-UP APPROACH 43 FIGURE 7 TOP-DOWN APPROACH 43 FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN HEALTHCARE DATA MONETIZATION MARKET 46 FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 46 FIGURE 10 DATA TRIANGULATION METHODOLOGY 48 FIGURE 11 DIRECT DATA MONETIZATION SEGMENT TO LEAD MARKET THROUGHOUT FORECAST PERIOD 51 FIGURE 12 CLOUD-BASED HEALTHCARE DATA MONETIZATION MODELS TO EXHIBIT HIGHER CAGR DURING FORECAST PERIOD 52 FIGURE 13 CLINICAL DATA SEGMENT TO LEAD MARKET THROUGHOUT FORECAST PERIOD 52 FIGURE 14 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE HEALTHCARE DATA MONETIZATION MARKET THROUGHOUT FORECAST PERIOD 53 FIGURE 15 NORTH AMERICA HELD LARGEST MARKET SHARE IN 2024 54 FIGURE 16 EXPONENTIALLY INCREASING DATA VOLUMES AND GENERATION OF LARGE AND COMPLEX HEALTHCARE DATASETS TO DRIVE MARKET 55 FIGURE 17 NORTH AMERICA TO CAPTURE MAJORITY OF HEALTHCARE DATA MONETIZATION MARKET SHARE IN 2030 56 FIGURE 18 CHINA TO BE FASTEST-GROWING HEALTHCARE DATA MONETIZATION MARKET GLOBALLY FROM 2025 TO 2030 56 FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND US DOMINATED MARKET IN NORTH AMERICA IN 2024 57 FIGURE 20 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 58 FIGURE 21 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: HEALTHCARE DATA MONETIZATION MARKET 59 FIGURE 22 US: ADOPTION OF ELECTRONIC HEALTH RECORDS, BY HOSPITAL SERVICE TYPE (2021) 61 FIGURE 23 COST OF GENOME ANALYSIS VS. VOLUME OF RAW DATA GENERATED, 2003–2023 62 FIGURE 24 US HEALTHCARE SPENDING, 2012–2030 (USD BILLION) 63 FIGURE 25 US: NUMBER OF DATA BREACHES (JANUARY 2009–MAY 2023) 69 FIGURE 26 DIRECT VS. INDIRECT DATA MONETIZATION 74 FIGURE 27 HEALTHCARE DATA MONETIZATION MARKET: SUPPLY CHAIN 79 FIGURE 28 HEALTHCARE DATA MONETIZATION ECOSYSTEM 81 FIGURE 29 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE DATA MONETIZATION SOLUTIONS, JANUARY 2015–MAY 2025 83 FIGURE 30 TOP APPLICANT COUNTRIES/JURISDICTIONS FOR PATENTS RELATED TO HEALTHCARE DATA MONETIZATION, JANUARY 2015–MAY 2025 84 FIGURE 31 HEALTHCARE DATA MONETIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS 94 FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 96 FIGURE 33 KEY BUYING CRITERIA, BY END USER 97 FIGURE 34 PRICING ANALYSIS: DATA MONETIZATION MARKET 102 FIGURE 35 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 103 FIGURE 36 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET SNAPSHOT 142 FIGURE 37 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET SNAPSHOT 169 FIGURE 38 REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2020–2024 205 FIGURE 39 HEALTHCARE DATA MONETIZATION MARKET: MARKET SHARE ANALYSIS, 2024 206 FIGURE 40 HEALTHCARE DATA MONETIZATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 209 FIGURE 41 HEALTHCARE DATA MONETIZATION MARKET: COMPANY FOOTPRINT 210 FIGURE 42 HEALTHCARE DATA MONETIZATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 215 FIGURE 43 EV/EBITDA OF KEY VENDORS 218 FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 218 FIGURE 45 HOSPITAL INFORMATION SYSTEMS MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 219 FIGURE 46 ORACLE: COMPANY SNAPSHOT 223 FIGURE 47 MICROSOFT: COMPANY SNAPSHOT 231 FIGURE 48 GOOGLE: COMPANY SNAPSHOT 238 FIGURE 49 SALESFORCE, INC.: COMPANY SNAPSHOT 245 FIGURE 50 SAP SE: COMPANY SNAPSHOT 257 FIGURE 51 SNOWFLAKE INC.: COMPANY SNAPSHOT 268 FIGURE 52 INFOSYS LIMITED: COMPANY SNAPSHOT 277 FIGURE 53 ACCENTURE: COMPANY SNAPSHOT 283 FIGURE 54 DOMO, INC.: COMPANY SNAPSHOT 292

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們